David F. Wiemer
Corporate Officer/Principal bij University of Iowa
Profiel
David F.
Wiemer is the founder of Terpenoid Therapeutics, Inc. which was founded in 2005.
He held the title of Director from 2012 to 2013.
Currently, he is a Professor at the University of Iowa.
Dr. Wiemer's education history includes an undergraduate degree from Marquette University and a doctorate from the University of Illinois.
Actieve functies van David F. Wiemer
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Iowa | Corporate Officer/Principal | - |
Eerdere bekende functies van David F. Wiemer
| Bedrijven | Functie | Einde |
|---|---|---|
Terpenoid Therapeutics, Inc.
 Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Oprichter | - |
Opleiding van David F. Wiemer
| Marquette University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Terpenoid Therapeutics, Inc.
Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Distribution Services |
